USANA Health Sciences, Inc. reiterated consolidated earnings guidance for the fiscal year 2021. For the year, the company expects consolidate net sales to be in the range of $1.24 billion to $1.28 billion and diluted EPS to be in the range of $6.15 to $6.50.